Woodline Partners LP Bausch Health Companies Inc. Transaction History

Woodline Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $3.18 Million - $4.34 Million	409,333 New	409,333 $4.34 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $3.82 Million - $4.82 Million	496,566 New	496,566 $4.08 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $6 - $7	-1 Reduced -0.0%	1,349,572 $8.48 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $2.37 Million - $7.94 Million	336,111 Added 33.16%	1,349,573 $11.3 Million
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $236,390 - $304,133	10,944 Added 1.09%	1,013,462 $23.2 Million
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $5.46 Million - $6.88 Million	-237,240 Reduced 19.14%	1,002,518 $27.7 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $25 Million - $30 Million	996,544 Added 409.74%	1,239,758 $34.5 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $6.67 Million - $7.95 Million	243,214 New	243,214 $7.13 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.